Optimal Objective-Based Experimental Design for Uncertain Dynamical Gene Networks with Experimental Error
暂无分享,去创建一个
Edward R. Dougherty | Roozbeh Dehghannasiri | Daniel N. Mohsenizadeh | E. Dougherty | Roozbeh Dehghannasiri
[1] A. Citri,et al. EGF–ERBB signalling: towards the systems level , 2006, Nature Reviews Molecular Cell Biology.
[2] G. A. Whitmore,et al. Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] Aniruddha Datta,et al. Bayesian Robustness in the Control of Gene Regulatory Networks , 2007, IEEE Transactions on Signal Processing.
[4] Edward R. Dougherty,et al. Effect of Function Perturbation on the Steady-State Distribution of Genetic Regulatory Networks: Optimal Structural Intervention , 2008, IEEE Transactions on Signal Processing.
[5] D. Riethmacher,et al. The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system. , 1998, Genes & development.
[6] H. Lane,et al. ERBB receptors and cancer: the complexity of targeted inhibitors , 2005, Nature Reviews Cancer.
[7] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[8] M. Leake,et al. Experimental approaches for addressing fundamental biological questions in living, functioning cells with single molecule precision , 2012, Open Biology.
[9] Aniruddha Datta,et al. Optimal infinite horizon control for probabilistic Boolean networks , 2006, 2006 American Control Conference.
[10] Peter A. J. Hilbers,et al. Optimal experiment design for model selection in biochemical networks , 2014, BMC Systems Biology.
[11] Aniruddha Datta,et al. Robust Intervention in Probabilistic Boolean Networks , 2007, 2007 American Control Conference.
[12] E. Wagner,et al. Liver Tumor Development c-Jun Antagonizes the Proapoptotic Activity of p53 , 2003, Cell.
[13] Byung-Jun Yoon,et al. Efficient experimental design for uncertainty reduction in gene regulatory networks , 2015, BMC Bioinformatics.
[14] Jinde Cao,et al. Stabilization of genetic regulatory networks with mixed time-delays: an adaptive control approach , 2015, IMA Journal of Mathematical Control and Information.
[15] N. Sampas,et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.
[16] S. Klewer,et al. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2–ErbB3 receptors , 2002, Nature Medicine.
[17] Edward R. Dougherty,et al. Intrinsically Optimal Bayesian Robust Filtering , 2014, IEEE Transactions on Signal Processing.
[18] Jinde Cao,et al. Global robust power-rate stability of delayed genetic regulatory networks with noise perturbations , 2010, Cognitive Neurodynamics.
[19] M. Volm,et al. Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas , 2005, Journal of Cancer Research and Clinical Oncology.
[20] Ilya Shmulevich,et al. Send Orders of Reprints at Reprints@benthamscience.org on the Limitations of Biological Knowledge , 2022 .
[21] J. Newsom-Davis,et al. Human muscle acetylcholine receptor alpha-subunit gene (CHRNA1) association with autoimmune myasthenia gravis in black, mixed-ancestry and Caucasian subjects. , 1996, Journal of autoimmunity.
[22] Yasser M Kadah,et al. Construction of gene regulatory networks using biclustering and bayesian networks , 2011, Theoretical Biology and Medical Modelling.
[23] Jianping Hua,et al. Dynamical modeling of uncertain interaction-based genomic networks , 2015, BMC Bioinformatics.
[24] Edward R. Dougherty,et al. Quantifying the Objective Cost of Uncertainty in Complex Dynamical Systems , 2013, IEEE Transactions on Signal Processing.
[25] Jinde Cao,et al. Stability analysis for genetic regulatory networks with delays: The continuous-time case and the discrete-time case , 2013, Appl. Math. Comput..
[26] M. Ringnér,et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.
[27] Anthony C. Atkinson,et al. Optimum Experimental Designs , 1992 .
[28] W. Talbot,et al. erbb3 and erbb2 Are Essential for Schwann Cell Migration and Myelination in Zebrafish , 2005, Current Biology.
[29] Michael P. H. Stumpf,et al. Maximizing the Information Content of Experiments in Systems Biology , 2013, PLoS Comput. Biol..
[30] Edward R. Dougherty,et al. Optimal Experimental Design for Gene Regulatory Networks in the Presence of Uncertainty , 2015, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[31] Y. Tu,et al. Quantitative noise analysis for gene expression microarray experiments , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[32] D. Sawyer,et al. The Role of Neuregulin 1 β /ErbB signaling in the heart , 2009 .
[33] T. Hudson,et al. Characterization of variability in large-scale gene expression data: implications for study design. , 2002, Genomics.
[34] H. Kitano. Systems Biology: A Brief Overview , 2002, Science.
[35] D. Stern,et al. ErbB2 is required for ductal morphogenesis of the mammary gland. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[36] Daoud Sie,et al. The T7-Primer Is a Source of Experimental Bias and Introduces Variability between Microarray Platforms , 2008, PloS one.
[37] J. Chan,et al. ErbB2 directly activates the exchange factor Dock7 to promote Schwann cell migration , 2008, The Journal of cell biology.
[38] Edward R. Dougherty,et al. A comparison study of optimal and suboptimal intervention policies for gene regulatory networks in the presence of uncertainty , 2014, EURASIP J. Bioinform. Syst. Biol..
[39] A. Barabasi,et al. Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.
[40] Edward R. Dougherty,et al. Probabilistic Boolean Networks - The Modeling and Control of Gene Regulatory Networks , 2010 .
[41] H. Kitano,et al. Computational systems biology , 2002, Nature.
[42] H. Lochmüller,et al. Congenital myasthenic syndromes: Achievements and limitations of phenotype‐guided gene‐after‐gene sequencing in diagnostic practice: A study of 680 patients , 2012, Human mutation.
[43] Béla Bollobás,et al. Graph Theory: An Introductory Course , 1980, The Mathematical Gazette.
[44] Ruth Nussinov,et al. Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.
[45] J. Banga,et al. Computational procedures for optimal experimental design in biological systems. , 2008, IET systems biology.
[46] Jason B. Lee,et al. Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3. , 2013, The Journal of clinical investigation.
[47] F. Maurer,et al. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[48] C. Arteaga,et al. ErbB3 ablation impairs PI3K/Akt-dependent mammary tumorigenesis. , 2011, Cancer research.